These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 2991600)

  • 1. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
    Emini EA; Hughes JV; Perlow DS; Boger J
    J Virol; 1985 Sep; 55(3):836-9. PubMed ID: 2991600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.
    Lemon SM; Barclay W; Ferguson M; Murphy P; Jing L; Burke K; Wood D; Katrak K; Sangar D; Minor PD
    Virology; 1992 May; 188(1):285-95. PubMed ID: 1314456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses.
    Hughes JV; Stanton LW
    J Virol; 1985 Aug; 55(2):395-401. PubMed ID: 2991564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.
    Rosen E; Stapleton JT; McLinden J
    Vaccine; 1993; 11(7):706-12. PubMed ID: 8393604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure and gene organization of human hepatitis A virus.
    Najarian R; Caput D; Gee W; Potter SJ; Renard A; Merryweather J; Van Nest G; Dina D
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2627-31. PubMed ID: 2986127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.
    Powdrill TF; Johnston JM
    J Virol; 1991 May; 65(5):2686-90. PubMed ID: 1850041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host antibody response to viral structural and nonstructural proteins after hepatitis A virus infection.
    Jia XY; Summers DF; Ehrenfeld E
    J Infect Dis; 1992 Feb; 165(2):273-80. PubMed ID: 1309847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV.
    Brown EA; Jansen RW; Lemon SM
    J Virol; 1989 Nov; 63(11):4932-7. PubMed ID: 2552172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.
    Mattioli S; Imberti L; Stellini R; Primi D
    J Virol; 1995 Sep; 69(9):5294-9. PubMed ID: 7543581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of short hepatitis virus A amino acid sequences into poliovirus antigenic determinants results in viable progeny.
    Sverdlov ED; Tsarev SA; Markova SV; Rostapshov VM; Azhikina TL; Chernov IP; Gorbalenya AE; Kolesnikova MS; Romanova LI; Teterina NL
    FEBS Lett; 1989 Nov; 257(2):354-6. PubMed ID: 2479578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of the VP1 gene from a Chinese strain of hepatitis A virus (HAV).
    Andonov AP; Lau PC; Chaudhary R
    Nucleic Acids Res; 1989 May; 17(9):3594. PubMed ID: 2542903
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous vaccination for hepatitis A and B.
    Flehmig B; Heinricy U; Pfisterer M
    J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic epitopes of the hepatitis A virus polyprotein.
    Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
    Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide.
    Haro I; Pinto RM; Gonzalez-Dankaart JF; Perez JA; Reig F; Bosch A
    Microbiol Immunol; 1995; 39(7):485-90. PubMed ID: 8569533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase.
    Baroudy BM; Ticehurst JR; Miele TA; Maizel JV; Purcell RH; Feinstone SM
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2143-7. PubMed ID: 2984684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs.
    Weitz M; Baroudy BM; Maloy WL; Ticehurst JR; Purcell RH
    J Virol; 1986 Oct; 60(1):124-30. PubMed ID: 3018280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.